Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE …

C Held, EM Hylek, JH Alexander, M Hanna… - European heart …, 2015 - academic.oup.com
Abstract Aim In the Apixaban for Reduction in Stroke and Other Thromboembolic Events in
Atrial Fibrillation (ARISTOTLE) trial, apixaban compared with warfarin reduced the risk of …
被引用次数：183 相关文章

Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE …

C Held, EM Hylek, JH Alexander… - European Heart …, 2015 - search.ebscohost.com
Abstract Aim In the Apixaban for Reduction in Stroke and Other Thromboembolic Events in
Atrial Fibrillation (ARISTOTLE) trial, apixaban compared with warfarin reduced the risk of …

[引用][C] Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the …

C Held, EM Hylek, JH Alexander, M Hanna, RD Lopes… - 2015 - repository.ubn.ru.nl
AIM: In the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial
Fibrillation (ARISTOTLE) trial, apixaban compared with warfarin reduced the risk of stroke …

Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE …

C Held, EM Hylek, JH Alexander… - Eur …, 2014 - academicworks.medicine.hofstra …
AIM: In the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial
Fibrillation (ARISTOTLE) trial, apixaban compared with warfarin reduced the risk of stroke …

Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE …

C Held, EM Hylek, JH Alexander, M Hanna… - European Heart …, 2014 - europepmc.org
Aim In the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial
Fibrillation (ARISTOTLE) trial, apixaban compared with warfarin reduced the risk of stroke …
[PDF] psu.edu

[PDF][PDF] Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the …

C Held, EM Hylek, JH Alexander, M Hanna, RD Lopes… - Citeseer
Aim In the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial
Fibrillation (ARISTOTLE) trial, apixaban compared with warfarin reduced the risk of stroke …

[引用][C] Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the …

C Held, EM Hylek, JH Alexander, M Hanna… - European Heart …, 2014 - cir.nii.ac.jp
Clinical outcomes and management associated with major bleeding in patients with atrial
fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial | CiNii …

Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE …

C Held, EM Hylek, JH Alexander, M Hanna, RD Lopes… - 2015 - pubmed.ncbi.nlm.nih.gov
Aim In the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial
Fibrillation (ARISTOTLE) trial, apixaban compared with warfarin reduced the risk of stroke …
[PDF] researchgate.net

[PDF][PDF] Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the …

C Held, EM Hylek, JH Alexander, M Hanna… - European Heart …, 2015 - researchgate.net
Aim In the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial
Fibrillation (ARISTOTLE) trial, apixaban compared with warfarin reduced the risk of stroke …

Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE …

C Held, EM Hylek, JH Alexander, M Hanna… - European Heart …, 2015 - diva-portal.org
Aim In the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial
Fibrillation (ARISTOTLE) trial, apixaban compared with warfarin reduced the risk of stroke …